The relationship of serum soluble receptor for advanced glycation end products (sRAGE) and carboxymethyl lysine (CML) to the incidence of diabetic nephropathy in persons with type 1 diabetes

Ronald Klein; Kayla Horak; Kristine E. Lee; Lorraine Danforth; Karen J. Cruickshanks; Michael Y. Tsai; Ronald E. Gangnon; Barbara E.K. Klein

doi:10.2337/dc17-0421

The relationship of serum soluble receptor for advanced glycation end products (sRAGE) and carboxymethyl lysine (CML) to the incidence of diabetic nephropathy in persons with type 1 diabetes

Ronald Klein, Kayla Horak, Kristine E. Lee, Lorraine Danforth, Karen J. Cruickshanks, Michael Y. Tsai, Ronald E. Gangnon, Barbara E.K. Klein

Laboratory Medicine and Pathology

Research output: Contribution to journal › Letter › peer-review

15 Scopus citations

Original language	English (US)
Pages (from-to)	e117-e119
Journal	Diabetes care
Volume	40
Issue number	9
DOIs	https://doi.org/10.2337/dc17-0421
State	Published - Sep 1 2017

Bibliographical note

Funding Information:
Acknowledgments. Ryan Schryver and Will Kelly of the Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, assisted with the technical editing and preparation of the manuscript. They received no additional compensation beyond their normal wages as employees of the University of Wisconsin–Madison for their assistance. Funding. This research was supported by the National Institutes of Health National Eye Institute grant EY016379 (R.K. and B.E.K.K.) and an unrestricted grant from Research to Prevent Blindness, New York, NY.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.2337/dc17-0421

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566284

OpenUrl availability

Full text

Cite this

Klein, R., Horak, K., Lee, K. E., Danforth, L., Cruickshanks, K. J., Tsai, M. Y., Gangnon, R. E., & Klein, B. E. K. (2017). The relationship of serum soluble receptor for advanced glycation end products (sRAGE) and carboxymethyl lysine (CML) to the incidence of diabetic nephropathy in persons with type 1 diabetes. Diabetes care, 40(9), e117-e119. https://doi.org/10.2337/dc17-0421

The relationship of serum soluble receptor for advanced glycation end products (sRAGE) and carboxymethyl lysine (CML) to the incidence of diabetic nephropathy in persons with type 1 diabetes. / Klein, Ronald; Horak, Kayla; Lee, Kristine E. et al.
In: Diabetes care, Vol. 40, No. 9, 01.09.2017, p. e117-e119.

Research output: Contribution to journal › Letter › peer-review

Klein, R, Horak, K, Lee, KE, Danforth, L, Cruickshanks, KJ, Tsai, MY, Gangnon, RE & Klein, BEK 2017, 'The relationship of serum soluble receptor for advanced glycation end products (sRAGE) and carboxymethyl lysine (CML) to the incidence of diabetic nephropathy in persons with type 1 diabetes', Diabetes care, vol. 40, no. 9, pp. e117-e119. https://doi.org/10.2337/dc17-0421

@article{7e0c8d8848924fdc8fd459454a0d99fa,

title = "The relationship of serum soluble receptor for advanced glycation end products (sRAGE) and carboxymethyl lysine (CML) to the incidence of diabetic nephropathy in persons with type 1 diabetes",

author = "Ronald Klein and Kayla Horak and Lee, {Kristine E.} and Lorraine Danforth and Cruickshanks, {Karen J.} and Tsai, {Michael Y.} and Gangnon, {Ronald E.} and Klein, {Barbara E.K.}",

note = "Funding Information: Acknowledgments. Ryan Schryver and Will Kelly of the Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, assisted with the technical editing and preparation of the manuscript. They received no additional compensation beyond their normal wages as employees of the University of Wisconsin–Madison for their assistance. Funding. This research was supported by the National Institutes of Health National Eye Institute grant EY016379 (R.K. and B.E.K.K.) and an unrestricted grant from Research to Prevent Blindness, New York, NY.",

year = "2017",

month = sep,

day = "1",

doi = "10.2337/dc17-0421",

language = "English (US)",

volume = "40",

pages = "e117--e119",

journal = "Diabetes care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

number = "9",

}

TY - JOUR

T1 - The relationship of serum soluble receptor for advanced glycation end products (sRAGE) and carboxymethyl lysine (CML) to the incidence of diabetic nephropathy in persons with type 1 diabetes

AU - Klein, Ronald

AU - Horak, Kayla

AU - Lee, Kristine E.

AU - Danforth, Lorraine

AU - Cruickshanks, Karen J.

AU - Tsai, Michael Y.

AU - Gangnon, Ronald E.

AU - Klein, Barbara E.K.

N1 - Funding Information: Acknowledgments. Ryan Schryver and Will Kelly of the Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, assisted with the technical editing and preparation of the manuscript. They received no additional compensation beyond their normal wages as employees of the University of Wisconsin–Madison for their assistance. Funding. This research was supported by the National Institutes of Health National Eye Institute grant EY016379 (R.K. and B.E.K.K.) and an unrestricted grant from Research to Prevent Blindness, New York, NY.

PY - 2017/9/1

Y1 - 2017/9/1

UR - http://www.scopus.com/inward/record.url?scp=85028032278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028032278&partnerID=8YFLogxK

U2 - 10.2337/dc17-0421

DO - 10.2337/dc17-0421

M3 - Letter

C2 - 28630056

AN - SCOPUS:85028032278

SN - 0149-5992

VL - 40

SP - e117-e119

JO - Diabetes care

JF - Diabetes care

IS - 9

ER -

The relationship of serum soluble receptor for advanced glycation end products (sRAGE) and carboxymethyl lysine (CML) to the incidence of diabetic nephropathy in persons with type 1 diabetes

Bibliographical note

UN SDGs

Access

OpenUrl availability

Other files and links

Cite this